Log in

Tel +1.201.308.8775

New Jersey Intellectual Property Law Association (NJIPLA)

29th Annual Pharmaceutical / Chemical Patent Practice Update

  • 10/22/2015
  • Hotel Woodbridge at Metropark

Registration is closed

29th Annual Pharmaceutical / Chemical Patent Practice Update

Hotel Woodbridge at Metropark
120 Wood Avenue South, Iselin, NJ
(732) 494-6200

Program:  Thursday, October 22nd     12:00 - 5:30 p.m.

Event Fee: $125 Corporate / Government Employee
                    $100 Corporate / Government Employee - NJIPLA Member

                     $225 General Registration
                     $180 General Registration - NJIPLA Member


12:00 - 1:00 p.m.     Luncheon

  1:00 - 1:05 p.m.     President’s Introduction
                                           Jon A. Chiodo, Johnson & Johnson

  1:05 - 1:10 p.m.     Opening Remarks by the Chair
                                           J. Eric Thies, Merck

  1:10 - 2:45 p.m.     Biotechnology and Pharmaceutical Issues in the
                                   European Patent Office (EPO)

                                         Inventive Step in Biotechnology, Examination
                                         Practice at the EPO

                                            Laurent Deleu, PhD, Examiner, EPO

                                        Medical Use Claims Under the European
                                        Patent Convention

                                           Virginie Merckling-Ruiz, PhD, Examiner, EPO

                                        Patentability of “Antibodies” Under the
                                        European Patent Convention

                                           Wolfram Meyer, PhD, Examiner, EPO

   2:45 - 2:55 p.m.       BREAK

   2:55 - 3:30 p.m.       The Road Less Traveled: The 505(b)(2) Pathway
                                       to FDA Approval

                                           Rabiya Kader, Sanofi

   3:30 - 4:05 p.m.       PTAB Update: Where We Are After Three Years
                                      of Challenges to Orange Book Patents

Gregory A. Morris, Honigman Miller Schwartz
                                           and Cohn LLP

  4:05 - 4:15 p.m.         BREAK

  4:15 - 4:50 p.m.         § 101: Is it really the “End of the World as We
                                       Know It”?
A breakdown of where we are now
                                       and what to expect

                                            Grantland G. Drutchas, McDonnell Boehnen
                                            Hulbert & Berghoff LLP

  4:50 - 5:30 p.m.        Patent Litigation Under the BPCIA:  Impact of
                                      Recent Decisions on Strategies for Addressing
                                      Potential Patent Disputes

                                            Elizabeth Weiswasser, Weil, Gotshal &
                                            Manges LLP

CLE:  4.5 NJ & NY
           4.0 PA